findmyKOL
Clinical trialNCT03908333WithdrawnPhase 1/PHASE2Interventional

High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer

SponsorMedical College of WisconsinEnrollment0Metastatic Pancreatic CancerPancreas CancerPancreatic Adenocarcinoma ResectablePancreatic CancerPancreatic Ductal AdenocarcinomaPancreatic Metastasis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Honorhealth Research Institute

    Scottsdale, Arizona, United States

  • University of California San Diego Moores Cancer Center

    San Diego, California, United States

  • Piedmont Cancer Institute, Pc

    Atlanta, Georgia, United States

  • Piedmont Cancer Institute, Pc

    Fayetteville, Georgia, United States

  • Piedmont Cancer Institute, Pc

    Newnan, Georgia, United States

  • Froedtert Hospital & the Medical College of Wisconsin

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 May 2019
Primary completion
1 May 2022
Completion
1 May 2023
Last update posted
30 May 2019
Registered enrollment
0
Registry id
NCT03908333

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.